Govt Job: For M.Pharm, M.Sc as Senior Research Fellow in AIIMS

All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the object to develop patterns of teaching Undergraduate and Post-graduate Medical Education in all its branches so as to demonstrate a high standard of Medical Education in India;

  • To bring together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity
  • To attain self-sufficiency in Post-graduate Medical Education.

Post: Senior Research Fellow (SRF)

Applications are invited for the post of Senior Research Fellow (SRF) in an ICMR-funded project (Project code: 1-1331) entitled “Genetic expression of monoaminergic neurotransmission related polymorphisms and their association with antidepressant response in Indian patients suffering from depression.” with a project duration of 3 years.

Minimum Qualifications: M.Sc, (Life Sciences / Pharmacology) degree holders with two years of research experience.

OR MBBS/BDS/ M.Pharm. degree holders Desirable qualification:

Experience in qRT-PCR-based techniques and clinical studies
Monthly emoluments: Rs. 35,000/- pm+ HRA permissible as per rule

Age Limit: Up to 35 years

Interested candidates are required to submit their applications with a CV by email to “neuropharmalab5002@gmail.com” or directly at 5th Floor, Room No. 5002, Convergence Block, Department of Pharmacology, AIIMS, New Delhi.

The shortlisted candidate will be informed about the date and venue of the interview by email of the telephone call.

The last date for submission of applications is October 25th, 2022.

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework